Financials Boston Scientific Corporation

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 15:29:09 14/07/2025 BST			5-day change	1st Jan Change
103.90 ^USD	+0.67%		-0.22%	+15.99%

07-07	Boston Scientific Says Farapulse Receives FDA Approval for Atrial Fibrillation	MT
07-07	Boston Scientific Corporation Receives U.S. Food and Drug Administration Approval to Expand the Instructions for Use Labeling for the Farapulse Pulsed Field Ablation System	CI

Projected Income Statement: Boston Scientific Corporation

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	9,913	11,888	12,682	14,240	16,747	19,476	21,557	23,658
Change	-	19.92%	6.68%	12.29%	17.61%	16.29%	10.68%	9.75%
EBITDA ¹	3,040	4,103	3,574	4,106	4,942	5,802	6,488	7,245
Change	-	34.97%	-12.89%	14.89%	20.36%	17.4%	11.83%	11.65%
EBIT ¹	1,917	3,010	3,241	3,738	4,529	5,392	6,048	6,741
Change	-	57.02%	7.67%	15.33%	21.16%	19.05%	12.18%	11.45%
Interest Paid ¹	-361	-341	-470	-265	-305	-363	-346.6	-320.2
Earnings before Tax (EBT) ¹	-138	1,076	1,141	1,985	2,282	3,352	4,211	4,945
Change	-	879.71%	6.04%	73.97%	14.96%	46.88%	25.62%	17.44%
Net income ¹	-173	985	642	1,570	1,853	2,819	3,529	4,118
Change	-	669.36%	-34.82%	144.55%	18.03%	52.15%	25.19%	16.69%
Announcement Date	03/02/21	02/02/22	01/02/23	31/01/24	05/02/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1
Net sales ¹	2,003	2,659	2,708	2,752	3,077	2,932	3,127	3,026	3,244	3,170	3,242	3,389	3,599	3,527	3,725	3,856	4,120	4,209	4,561	4,663	4,894	4,856	5,090	5,166	5,376	5,352	5,617	5,556
Change	-	32.75%	1.84%	1.62%	11.81%	-4.71%	6.65%	-3.23%	7.2%	-2.28%	2.27%	4.53%	6.2%	-2%	5.61%	3.52%	6.85%	2.16%	8.36%	2.24%	4.96%	-0.79%	4.82%	1.5%	4.07%	-0.46%	4.95%	-1.08%
EBITDA ¹	330	705	785	937	856	838	1,109	1,055	898	892	928	947	1,052	1,011	1,095	1,316	1,430	1,453	1,374	1,456	1,432	1,392	1,466	1,568	1,639	1,626	1,719	-
Change	-	113.64%	11.35%	19.36%	-8.64%	-2.1%	32.34%	-4.87%	-14.88%	-0.67%	4.04%	2.05%	11.09%	-3.9%	8.31%	20.18%	8.66%	1.61%	-5.44%	5.97%	-1.64%	-2.84%	5.37%	6.94%	4.52%	-0.79%	5.7%	-
EBIT ¹	252	621	495	669	773	750	819	781	818	810	833	865	964	919	990	1,012	1,119	1,147	1,251	1,350	1,353	1,306	1,387	1,448	1,509	1,506	1,595	1,574
Change	-	146.43%	-20.29%	35.15%	15.55%	-2.98%	9.2%	-4.64%	4.74%	-0.98%	2.84%	3.84%	11.45%	-4.67%	7.73%	2.22%	10.57%	2.5%	9.07%	7.91%	0.21%	-3.43%	6.18%	4.35%	4.25%	-0.22%	5.91%	-1.29%
Charge d'intérêts ¹	-91	-86	-96	-82	-86	-86	-87	-279	-64	-63	-64	-65	-70	-66	-65	-69	-77	-79	-80	-82	-95.78	-94.49	-94.21	-84	-83.8	-80.8	-80.6	-80
Earnings before Tax (EBT) ¹	-181	-227	248	325	149	483	120	156	345	245	396	444	426	610	505	608	420	669	585	805	834	807	907.5	957.5	1,037	1,051	1,126	948
Change	-	-25.41%	209.25%	31.05%	-54.15%	224.16%	-75.16%	30%	121.15%	-28.99%	61.63%	12.12%	-4.05%	43.19%	-17.21%	20.4%	-30.92%	59.29%	-12.56%	37.61%	3.6%	-3.24%	12.45%	5.51%	8.3%	1.35%	7.14%	-15.81%
Net income ¹	-153	-169	138	327	172	405	80	97	246	174	126	300	261	505	504	495	324	469	566	674	715.4	695.5	769.5	829.6	883.8	888.5	943.9	875.7
Change	-	-10.46%	181.66%	136.96%	-47.4%	135.47%	-80.25%	21.25%	153.61%	-29.27%	-27.59%	138.1%	-13%	93.49%	-0.2%	-1.79%	-34.55%	44.75%	20.68%	19.08%	6.14%	-2.78%	10.63%	7.81%	6.53%	0.54%	6.23%	-7.22%
Announcement Date	29/07/20	28/10/20	03/02/21	28/04/21	27/07/21	27/10/21	02/02/22	27/04/22	27/07/22	26/10/22	01/02/23	26/04/23	27/07/23	26/10/23	31/01/24	24/04/24	24/07/24	23/10/24	05/02/25	23/04/25	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Boston Scientific Corporation

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	7,409	7,140	8,007	8,237	10,332	7,491	4,228	251
Change	-	-3.63%	12.14%	2.87%	25.43%	-27.5%	-43.56%	-94.06%
Announcement Date	03/02/21	02/02/22	01/02/23	31/01/24	05/02/25	-	-	-

¹USD in Million

Estimates

Cash Flow Forecast: Boston Scientific Corporation

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	376	554	588	711	790	851.1	831.5	897.5
Change	-	47.34%	6.14%	20.92%	11.11%	7.73%	-2.3%	7.94%
Free Cash Flow (FCF) ¹	1,132	1,316	938	1,792	2,645	2,797	3,087	4,248
Change	-	16.25%	-28.72%	91.04%	47.6%	5.76%	10.36%	37.59%
Announcement Date	03/02/21	02/02/22	01/02/23	31/01/24	05/02/25	-	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: Boston Scientific Corporation

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	30.67%	34.51%	28.18%	28.83%	29.51%	29.79%	30.1%	30.62%
EBIT Margin (%)	19.34%	25.32%	25.56%	26.25%	27.04%	27.68%	28.06%	28.49%
EBT Margin (%)	-1.39%	9.05%	9%	13.94%	13.63%	17.21%	19.53%	20.9%
Net margin (%)	-1.75%	8.29%	5.06%	11.03%	11.06%	14.48%	16.37%	17.41%
FCF margin (%)	11.42%	11.07%	7.4%	12.58%	15.79%	14.36%	14.32%	17.95%
FCF / Net Income (%)	-654.34%	133.6%	146.11%	114.14%	142.74%	99.23%	87.47%	103.14%
Profitability
ROA	4.49%	7.42%	7.6%	8.87%	10%	9.73%	10.62%	10.45%
ROE	9.44%	14.12%	14.38%	16.27%	18.15%	18.26%	18.18%	17.52%
Financial Health
Leverage (Debt/EBITDA)	2.44x	1.74x	2.24x	2.01x	2.09x	1.29x	0.65x	0.03x
Debt / Free cash flow	6.55x	5.43x	8.54x	4.6x	3.91x	2.68x	1.37x	0.06x
Capital Intensity
CAPEX / Current Assets (%)	3.79%	4.66%	4.64%	4.99%	4.72%	4.37%	3.86%	3.79%
CAPEX / EBITDA (%)	12.37%	13.5%	16.45%	17.32%	15.99%	14.67%	12.82%	12.39%
CAPEX / FCF (%)	33.22%	42.1%	62.69%	39.68%	29.87%	30.42%	26.93%	21.13%
Items per share
Cash flow per share ¹	1.064	1.304	1.06	1.71	2.312	2.407	3.189	4.52
Change	-	22.53%	-18.73%	61.36%	35.16%	4.11%	32.49%	41.75%
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	10.82	11.66	12.26	13.16	14.76	17.13	19.26	21.89
Change	-	7.78%	5.14%	7.3%	12.23%	16.06%	12.41%	13.66%
EPS ¹	-0.12	0.69	0.45	1.07	1.25	1.917	2.368	2.736
Change	-	675%	-34.78%	137.78%	16.82%	53.37%	23.52%	15.56%
Nbr of stocks (in thousands)	1,431,921	1,424,992	1,432,311	1,464,983	1,473,827	1,479,446	1,479,446	1,479,446
Announcement Date	03/02/21	02/02/22	01/02/23	31/01/24	05/02/25	-	-	-